Intravenous And/Or Peripheral Saline Lock Insertion and Maintenance

Intravenous And/Or Peripheral Saline Lock Insertion and Maintenance

<p>Polic ies &amp; Proc edures </p><p>Title: <strong>INTRAVENOUS AND/OR PERIPHERAL </strong><br><strong>SALINE LOCK INSERTION AND MAINTENANCE </strong></p><p>ID Number:&nbsp;<strong>1118 </strong></p><p></p><ul style="display: flex;"><li style="flex:1">Authoriza tion </li><li style="flex:1">Sourc e:&nbsp;Nursing </li></ul><p>Da te&nbsp;Revised: September&nbsp;2013 Da te&nbsp;Effec tive:&nbsp;Ma y 1999 Da te&nbsp;Rea ffirmed:&nbsp;Ma y 2015 </p><p>Sc ope:&nbsp;<strong>SHR &amp; Affiliates </strong></p><p>[X] SHR Nursing Pra c tic e C ommittee </p><p><em>Any PR I N T E D ve &nbsp; r si o n of t his d oc &nbsp; ume nt &nbsp; i s o n l y a c &nbsp; c u r a t e &nbsp; up to the d a t e o f p r i n ting 22- J u l -15. S a s k a t o on H e a l th Re &nbsp; g i o n (SHR) c a n not &nbsp; gua r a n t e e t he c &nbsp; urre nc y &nbsp; o r ac c u r a c y &nbsp; of any p r i n te &nbsp; d p o l ic &nbsp; y. A l w ays &nbsp; r e fe r to &nbsp; the P o l ic &nbsp; ie s &nbsp; a nd P r o c &nbsp; e du r e s &nbsp; site f o r &nbsp; t he mo s t c &nbsp; urre nt &nbsp; ve rsi o ns &nbsp; of doc &nbsp; ume nts &nbsp; i n e &nbsp; ffe c t. &nbsp; SHR a c &nbsp; c e p t s &nbsp; no re &nbsp; s p on s i b i lity f o r u s e &nbsp; o f t his m a t e &nbsp; ri a l by any pe &nbsp; r s o n or o r g a n iz a t i o n not a s s o c &nbsp; i a t e d w i th SHR. No p a r t o f t his d oc &nbsp; u me nt &nbsp; may be r e &nbsp; p r o duc e d &nbsp; i n a n y f o r m f o r pub l ic &nbsp; a t i o n w i th o ut pe r m i ssi o n of S HR. </em></p><p><strong>DEFINITIONS </strong></p><p><strong>Flushing </strong>– Injec tion of a&nbsp;solution into the intra&nbsp;venous (IV) c a theter/c a p to prevent mixing of inc ompa tible&nbsp;solutions a nd c lea n the c a theter of blood or fibrin buildup. </p><p><strong>Turbulent flush technique </strong>– A method of flushing using a “stop-sta&nbsp;rt” tec&nbsp;hnique whic&nbsp;h “sc rubs” the </p><p>inside of the c&nbsp;a theter lumen, preventing the build-up of fibrin or medic a tion residue. </p><p><strong>1. PURPOSE </strong></p><p>1.1 To&nbsp;minimize the risks&nbsp;of infec tion a nd other c omplic a tions a ssoc ia ted with the&nbsp;insertion a nd ma intena nc e&nbsp;of intra venous c a theters. </p><p><strong>2. POLICY </strong><br>2.1 <strong>Who may start IV </strong></p><p>• RN/RPN/G N c ompetent in IV sta rts (NIC U-Level 2 orienta ted RN only) • Nursing Students under direc t&nbsp;RN/G N/RPN/LPN/G PN supervision • LPN/G PN who ha ve suc c essfully c ompleted the IV/Blood Administra tion C ourse • Home Intra&nbsp;venous Thera py Progra m (HITP) – RN’s only </p><p>2.2 A&nbsp;presc riber order is required to sta rt a n IV exc ept in a n emergenc y situa tion or for resta rts. </p><p>2.3 <strong>Special C onsiderations </strong></p><p>2.3.1 Ma&nbsp;ximum of 2 insertion a ttempts per nurse, then c onsult more experienc ed personnel. 2.3.2 Site&nbsp;will be&nbsp;monitored visua&nbsp;lly every shift or point of c a re c onta c t (refers to Home C a re visit), Pedia tric s: q1h when IV fluid is infusing a nd when pa tient c ompla ins of pa in or tenderness a t IV site or ha s a n unexpla ined fever. </p><p>2.3.3 Ha&nbsp;nd hygiene will a&nbsp;lwa ys be&nbsp;performed a&nbsp;s per polic y before a nd a fter pa lpa ting c a theter insertion sites a s well a s before&nbsp;a nd&nbsp;a fter inserting, repla c ing, a c c essing or repa iring&nbsp;a n IV c a theter or dressing a n IV site. </p><p><em>P a ge 1 of 6 </em></p><ul style="display: flex;"><li style="flex:1"><em>P o l ic ie s &amp; Pr o c e du r e s: Intr a ve nous and/or Pe r i p he r a l S a l i n e &nbsp; l o c k I ns e r t i o n and Ma i n te n a nc e </em></li><li style="flex:1"><em>I . D. # &nbsp; 1118 </em></li></ul><p></p><p>2.3.4 The&nbsp;nurse will&nbsp;a ttempt to a spira te&nbsp;the c&nbsp;a theter for blood return to a ssess c a theter func tion prior to use. </p><p>2.3.5 Direc&nbsp;t luer loc k c onnec tions will be&nbsp;used for c ontinuous infusions. 2.3.6 C&nbsp;ontinuously running solutions c onta ining medic a tions (e.g. hepa rin, insulin) must run on the prima&nbsp;ry port (A) of the IV pump. </p><p><strong>Note: </strong><em>A l l C h e mo t h e r a py mu s t b e &nbsp; i nfus e d on s e c onda r y p o r t ( B). </em></p><p>2.3.7 IV&nbsp;ba gs a nd&nbsp;syringes with medic a tion a dded by nurse must ha ve a&nbsp;medic a tion la bel c ompleted&nbsp;a nd&nbsp;a tta c hed. </p><p>2.3.8 Pedia&nbsp;tric a&nbsp;rea s - IV pump must be used with a ll IV infusions.&nbsp;All IV ba gs a nd syringes must be la&nbsp;beled, even if no medic a tion is a dded. </p><p>2.4 <strong>IV site preparation </strong></p><p>2.4.1 C&nbsp;hlorhexidine 2% or C hlorhexidine 2%/Alc ohol 70% will be used to c lea nse site. </p><p><strong>Note: </strong><em>F o r i n f a n ts un d er 2 month s , use &nbsp; A l c o hol 70 % . </em><strong>Note: </strong><em>A nt i s e p t ic m ust &nbsp; b e a l l o wed t o a i r &nbsp; d r y o n i n s e r ti o n s ite b e f o r e c a t h e t e r i n s e r ti o n. </em></p><p>2.4.2 Pedia&nbsp;tric a&nbsp;rea s: a&nbsp;topic a l a na esthetic&nbsp;c rea m&nbsp;ma y be a pplied (presc riber order required) before IV insertion to ma&nbsp;na ge&nbsp;pa in.&nbsp;See produc&nbsp;t instruc tions. </p><p>2.5 <strong>IV site dressing </strong></p><p>2.5.1 Sterile,&nbsp;tra nspa rent, semi permea ble&nbsp;dressing is rec ommended. 2.5.2 Sterile&nbsp;ga uze&nbsp;dressing will be used with sterile ta&nbsp;pe to sec&nbsp;ure hub (e.g. Steri-strips) when a pa&nbsp;tient is dia phoretic&nbsp;or if site is bleeding or oozing until resolved. </p><p>2.5.3 Dressing&nbsp;will be&nbsp;repla c ed&nbsp;when da mp, loosened or visibly soiled or when IV site c ha nged. </p><p>2.5.4 The&nbsp;da te&nbsp;a nd&nbsp;time of IV insertion will be written on the dressing. 2.5.5 Pedia&nbsp;tric IV ta&nbsp;ping proc&nbsp;edure: <br>2.5.5.1 Use&nbsp;a tra&nbsp;nspa rent, semi permea ble&nbsp;dressing to sec ure c a theter. 2.5.5.2 Keep&nbsp;site visible – do not ta&nbsp;pe over. 2.5.5.3 Ta&nbsp;pe fingers/toes&nbsp;a nd&nbsp;wrist/a nkle&nbsp;to IV boa&nbsp;rd (if using). Lea ve one end of ta pe&nbsp;doubled over for ea sy remova l. <br>2.5.5.4 Use&nbsp;double sided ta&nbsp;pe then c&nbsp;over with single sided ta pe to sec ure a rm/leg to the a&nbsp;rm boa&nbsp;rd (NIC&nbsp;U: ma y dea den the ta pe with c otton ba ll to protec t the skin). <br>2.5.5.5 Use&nbsp;a n IV site protec tor (i.e. IV House®) to protec t the IV site. 2.5.5.6 Use&nbsp;tubula r ga uze&nbsp;or a&nbsp;thin c otton soc k to c over site or over a rm/foot boa rd if required. Do not use ga uze ba nda ge wra p. <br>2.5.5.7 No&nbsp;sc issors to be used when removing ta pe or a rm/footboa rds. 2.5.5.8 C&nbsp;hec k ta pe/a rm boa rds every shift a nd c ha nge q48-72h (exc ept ta pe a t IV site). </p><p><em>P a ge 2 of 6 </em></p><ul style="display: flex;"><li style="flex:1"><em>P o l ic ie s &amp; Pr o c e du r e s: Intr a ve nous and/or Pe r i p he r a l S a l i n e &nbsp; l o c k I ns e r t i o n and Ma i n te n a nc e </em></li><li style="flex:1"><em>I . D. # &nbsp; 1118 </em></li></ul><p></p><p>2.6 <strong>Flushing </strong></p><p>2.6.1 The&nbsp;IV c&nbsp;a theter will be&nbsp;flushed prior to use to a ssess c a theter func tion. 2.6.2 The&nbsp;IV c&nbsp;a theter will be&nbsp;flushed following a&nbsp;c c ess using turbulent flush tec hnique to ma inta in pa tenc y. </p><p><strong>Note: </strong><em>Pri o r to &nbsp; ac c e s sing &nbsp; a n y p o r t o r c ap, c l e an t he surf a c e w i th a n a l c o hol s w a b f or </em><br><em>15 s e c onds u s ing fric ti o n and a tw i sting m ot i o n. </em></p><p>2.6.3 Adults:&nbsp;3mls 0.9% sodium c hloride every 24 hours a nd prn following ea c h use. <br>Pedia tric s: 1-2 mls of 0.9% sodium c hloride q6h &amp; prn. </p><p><strong>Note: </strong><em>PIC U: &nbsp; 0.5–1 ml 0.9% s o d i um c hl o r i d e &nbsp; p r e a n d b e t w e en med i c &nbsp; a t i o n(s) th e n 1 -2 ml 0.9% so d i um c hl o r i d e &nbsp; f o l l o w i n g m e d i c &nbsp; a t i o n. </em></p><p>Neona tes: 0.5 mls (or double c a theter &amp; extension a mount) 0.9% sodium c hloride every 4-6 hours. </p><p>2.7 <strong>IV site change </strong></p><p>2.7.1 Adults:&nbsp;site will&nbsp;be c&nbsp;ha nged&nbsp;every 96 hours or a s soon a s possible when a septic tec hnique&nbsp;during insertion c a nnot be ensured or with signs of phlebitis or infec tion or when dysfunc tiona l. Pedia tric s:&nbsp;site will&nbsp;be c&nbsp;ha nged&nbsp;only when dysfunc tiona l. </p><p>2.8 <strong>Tubing &amp;&nbsp;Solution Change </strong></p><p>2.8.1 C&nbsp;ontinuous use tubing, sec onda ry sets &amp; a dd-on devic es (ie. medic a tion filters, bridges, a da pters) will be c ha nged every 96 hours, with IV site c ha nge or immedia tely if c onta mina tion or system integrity suspec ted </p><p><strong>Note: </strong><em>C e r t a i n m ed i c a t i o ns r e q u ire &nbsp; m o r e fr e q u e n t tu b i n g / filt e r c h ange s . R e f e r t o IV </em><br><em>Med i c a t i o n R e f e r e n c e &nbsp; Manua l . </em></p><p>2.8.2 Lipid&nbsp;a nd&nbsp;a ll Pa rentera l Nutrition (PN) solutions, filter, a da pters &amp; tubing will be c ha nged&nbsp;every 24 hours. </p><p>2.8.3 Blood&nbsp;&amp; blood produc ts - a s per “Blood, Blood C omponents a nd Pla sma&nbsp;Protein <br>Produc ts - Administra tion of” polic y. </p><p>2.8.4 All&nbsp;tubing will be la&nbsp;beled with the da&nbsp;te &amp;&nbsp;time it wa&nbsp;s sta rted, da te&nbsp;&amp; time&nbsp;to be disc a rded&nbsp;or c ha nged, a nd initia ls of c a regiver. </p><p>2.8.5 IV&nbsp;solutions must be c ha nged a t lea st every 96 hours, with tubing c ha nges a nd with IV site c&nbsp;ha nges </p><p><strong>Note: </strong><em>M ed i c a t i o n add i ti v es and s p ec i fic &nbsp; s o l u ti o ns may r e q u ire m o r e fr e q u e n t c hanges due &nbsp; to s t a b i lity; r e f e r t o s p ec i fic &nbsp; p o l ic i e s a n d &nbsp; r e f e r e n c e s . </em></p><p><em>P a ge 3 of 6 </em></p><ul style="display: flex;"><li style="flex:1"><em>P o l ic ie s &amp; Pr o c e du r e s: Intr a ve nous and/or Pe r i p he r a l S a l i n e &nbsp; l o c k I ns e r t i o n and Ma i n te n a nc e </em></li><li style="flex:1"><em>I . D. # &nbsp; 1118 </em></li></ul><p></p><p>2.9 <strong>Pump Pressures/Alarm </strong></p><p>2.9.1 Pedia&nbsp;tric a&nbsp;rea s: Defa ulted to 2 PSI. Pa tient a nd IV pump pressures will be c ha rted a s per unit polic y. Neona tes: IV pump pressure will be noted a t sta rt of infusion a nd limit set a c c ordingly. C ha nges in PSI will be&nbsp;c hec ked&nbsp;hourly. Adults: Pump pressures defa ult setting - 10 PSI. </p><p>2.10 <strong>LPN/GPN Role – IV Therapy </strong></p><p><strong>Note: </strong><em>R e f e r t o &nbsp; Append i x A</em><strong>. </strong></p><p><strong>3. PROCEDURES </strong></p><p><strong>Note: </strong><em>R e f e r t o &nbsp; P e r r y , Pott e r &amp; O s t e n d o r f 2014 C linic a l N ursing Skills &amp; T e c h n i q u e s 8</em><sup style="top: -0.21em;"><em>th </em></sup><em>E d i ti o n. </em></p><p>3.1 Insertion&nbsp;of a&nbsp;Periphera l Intra venous C a theter<em>: </em>pa ges 697 - 708 3.2 C&nbsp;ha nging&nbsp;Solutions, Regula ting Intra venous Flow Ra te, C ha nging Infusion Tubing, <br>Disc ontinuing&nbsp;Short Periphera l Intra venous Ac c ess<strong>: </strong>pa ges 708 - 724. </p><p>3.3 <strong>Document </strong></p><p>••••••</p><p>Insertion a nd ongoing c a re of IV on a ppropria te rec ord every shift a nd prn C a re&nbsp;of site, da te of site c ha nge a nd loc a tion of site on the c a re pla n Rea son for fa iling to re-esta blish new IV site a s indic a ted Da te&nbsp;IV wa&nbsp;s esta blished&nbsp;on the IV dressing Solution type a&nbsp;nd volumes on a fluid ba&nbsp;la nc e&nbsp;sheet. Medic a tions a dded&nbsp;to solution on medic a tion a dministra tion rec ord. </p><p><strong>4. REFERENC&nbsp;ES </strong></p><p>Americ a n Hea rt Assoc ia tion (2012) PALS Provider Ma nua l Assoc ia tion for Professiona l in Infec tion C ontrol a nd Epidemiology – G rota , P. (2014) APIC&nbsp;Text in Infec tion C ontrol &amp; Epidemiology. 4<sup style="top: -0.21em;">th </sup>Edition. Wa sh, USA: C ha pter 24 –Intra va sc ula r Devic e Infec tions </p><p>C enters for Disea se&nbsp;C ontrol a nd&nbsp;Prevention (2011). G uidelines for the Prevention of Intra va sc ula r </p><p>C a theter – Rela ted Infec tions.&nbsp;<a href="/goto?url=http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html" target="_blank">http://www.c dc .gov/h</a><a href="/goto?url=http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html" target="_blank">i</a><a href="/goto?url=http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html" target="_blank">c </a><a href="/goto?url=http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html" target="_blank">p</a><a href="/goto?url=http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html" target="_blank">a c /b</a><a href="/goto?url=http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html" target="_blank">s</a><a href="/goto?url=http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html" target="_blank">i/</a><a href="/goto?url=http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html" target="_blank">b</a><a href="/goto?url=http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html" target="_blank">s</a><a href="/goto?url=http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html" target="_blank">i-</a><a href="/goto?url=http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html" target="_blank">g</a><a href="/goto?url=http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html" target="_blank">u</a><a href="/goto?url=http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html" target="_blank">i</a><a href="/goto?url=http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html" target="_blank">d</a><a href="/goto?url=http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html" target="_blank">e</a><a href="/goto?url=http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html" target="_blank">l</a><a href="/goto?url=http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html" target="_blank">in</a><a href="/goto?url=http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html" target="_blank">e</a><a href="/goto?url=http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html" target="_blank">s</a><a href="/goto?url=http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html" target="_blank">-2011.html </a></p><p>C ollege&nbsp;of Physic ia ns a nd Surgeons of Sa ska tc hewa n -La bora tory Qua lity Assura nc e&nbsp;Progra m (2004) Tra&nbsp;nsfusion G uidelines for Hospita ls in Sa ska tc hewa n. </p><p>C ompetenc y Profile&nbsp;for Lic ensed Pra c tic a l Nurses of Sa ska tc hewa n, Version 2 (July 11, 2005): Sa ska tc hewa n Assoc ia tion of Lic ensed Pra c tic a l Nurses a nd&nbsp;Alberta Hea&nbsp;lth a nd Wellness Hea lth Workforc e&nbsp;Pla nning&nbsp;Bra nc h, Edmonton. </p>

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    6 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us